NASDAQ NMS - GLOBAL MARKET · ACET
-4.24% · -$0.3500 · Vol 88.6K
Market closed · last close 4:00 PM ET · price as of 16:00:00 ET
Adicet Bio Inc

Adicet Bio Inc

Biotechnology
$7.90

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is ACET moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Adicet Bio Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2020
Employees
102
Country
US

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. It is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. The company's main product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, and is being developed for the potential treatment of autoimmune diseases. Additionally, it is pursuing ADI-212, a next-generation gene-edited and armored clinical candidate designed to target prostate-specific membrane antigen (PSMA).

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$8.25
Day high
$8.30
Day low
$7.88
Previous close
$8.25
52W high
$8.30
-4.82% from high
52W low
$7.31
60% of range
Market cap
$77.1M
EPS
$-2.8200
Shares out
9.3M
Volume
88.6K
VWAP
$8.03
Price history computed in-house
1W
-2.47%
SMA 50 $7.97 · below
SMA 200 $7.97 · below
52W position 60%
Veridion warehouse edge

Warehouse intelligence for ACET.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

ACET insider activity

Adicet Bio Inc

Score
Coverage building
Pressure
Net buying
Filings
13
Buys / sells
5 / 8
Net value
$5.9M
Insiders
6
Named filers
OL
ORBIMED ADVISORS LLC
Insider
Leadership
RL
RA Capital Healthcare Fund LP
Insider
Leadership
AB
Aftab Blake
Insider
Leadership
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Net buying: $5.9M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-04-132026-02-20RA Capital Healthcare Fund LPInsiderbuy$7.2774,7511,182,624$543KSEC Form 4
2026-04-132026-02-19RA Capital Healthcare Fund LPInsiderbuy$7.2174,2681,107,873$535KSEC Form 4
2026-04-132026-02-18RA Capital Healthcare Fund LPInsiderbuy$7.0474,5771,033,605$525KSEC Form 4
2026-04-092026-04-08ORBIMED ADVISORS LLCInsidersell$6.5240,416Not reported$264KSEC Form 4
2026-04-092026-04-08ORBIMED ADVISORS LLCInsidersell$6.2932,523Not reported$205KSEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 8 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

ACET contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ACET in this window.
Lobbying spend

ACET lobbying filings, year to date.

Registered lobbying filings matched to Adicet Bio Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ACET in this window.
Latest news · ACET
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for ACET.
Options
Sovereign unlock shows live options positioning for ACET.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.